Loading...
Loading...
BSX-PA| Name | Value |
|---|---|
| Revenues | 4,209.0M |
| Cost of Revenue | 1,312.0M |
| Gross Profit | 2,897.0M |
| Operating Expense | 2,179.0M |
| Operating I/L | 718.0M |
| Other Income/Expense | -49.0M |
| Interest Income | 0.0M |
| Pretax | 669.0M |
| Income Tax Expense | 200.0M |
| Net Income/Loss | 468.0M |
Boston Scientific Corporation is a global leader in developing, manufacturing, and marketing medical devices for interventional medical specialties. The company's MedSurg, Rhythm and Neuro, and Cardiovascular segments offer a wide range of medical technologies, including devices for gastrointestinal, pulmonary, urological, and pelvic conditions, as well as implantable cardiac devices, spinal cord stimulators, deep brain stimulation systems, interventional cardiology products, and therapies for arterial, venous, and structural heart conditions. Boston Scientific generates revenue through the sale of these medical devices and technologies, providing diagnostic and treatment solutions for a diverse range of medical conditions.
